511509 — Vivo Bio Tech Balance Sheet
0.000.00%
- IN₹720.80m
- IN₹1.25bn
- IN₹466.73m
- 72
- 78
- 46
- 76
Annual balance sheet for Vivo Bio Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 11.7 | 17.1 | 13.7 | 13.9 | 12.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 120 | 136 | 192 | 360 | 321 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 271 | 260 | 318 | 472 | 419 |
Net Property, Plant And Equipment | 410 | 824 | 800 | 815 | 772 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 795 | 1,225 | 1,230 | 1,371 | 1,432 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 218 | 244 | 250 | 379 | 278 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 370 | 765 | 712 | 827 | 653 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 425 | 459 | 519 | 544 | 779 |
Total Liabilities & Shareholders' Equity | 795 | 1,225 | 1,230 | 1,371 | 1,432 |
Total Common Shares Outstanding |